SME Times is powered by   
Search News
Just in:   • Centre exempts nuclear power goods from customs duty for past imports  • Indian markets trade higher despite West Asia tensions  • Corporate lending grows at fastest pace in Q1: BOK  • Adani Ports secures 10-year marine services for Argentina's 1st LNG export to India  • Indian auto industry sees best-ever May retail sales at over 25.3 lakh units 
Last updated: 29 Jul, 2024  

Agriculture.9.thmb.jpg Medicinal plants exports jump 137 percent

Agriculture.9.jpg
   Top Stories
» Centre exempts nuclear power goods from customs duty for past imports
» Indian markets trade higher despite West Asia tensions
» Sensex, Nifty open 1 pc lower amid West Asia tensions, weak global cues
» India clocks robust 7.7 pc GDP growth in 2025-26, Q4 growth at 7.8 pc
» RBI keeps repo rate unchanged at 5.25 pc, maintains ‘Neutral’ stance
SME Times News Bureau | 09 Aug, 2012
India continues to be ranked the world's second largest exporter of medicinal plants after China as the trade in herbals registered around 137 percent growth in last five years, an official said Wednesday.

According to the Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoepathy (AYUSH), India has 5,662 varieties of medicinal plants and of these trading takes place in 460, while 178 are exported in huge quantities (over 100 metric tonnes per year).

The department is part of the union health ministry and works to propagate Indian systems of medicine.

"India ranks second in the world after China in export of medicinal plants. The global trade of medicinal plants stands at $7,592 million in 2011, and of these China and India's share was around $1,329 million and $790 million respectively," Anil Kumar, secretary (AYUSH), told reporters.

India has registered a growth of 137 percent in export of medicinal plants in global market from Rs.554 crore in 2005-06 to Rs.1,318 crore in 2010-11.

Several schemes have been initiated to maintain the growth of herbal exports.

The department has taken several steps to deal with the quality control issues of Ayurveda, Unani, Siddha and Homoepathy drugs in India.

"These include notification of the shelf life for drugs, amendment in labelling and licensing provisions and initiating action for setting up of a more effective central regulatory mechanism," Kumar said.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹94.2
₹92.5
UK Pound
₹128.85
₹124.8
Euro
₹112.2
₹108.45
Japanese Yen ₹59.85 ₹58
As on 06 May, 2026
  Daily Poll
What is the biggest war impact on MSMEs?
 Export Disruption
 Raw Material Spike
 Freight Cost Surge
 Payment Delays
 Currency Volatility
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter